Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas

Veterinary and Comparative Oncology

Volumn 7, Issue 3, 2009, Pages 173-180

  Rossmeisl Jr , J H ^a   Robertson, J L ^a   Zimmerman, K L ^a   Higgins, M A ^b   Geiger, D A ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b Canada West Veterinary Specialists and Critical Care Hospital   (Canada)

Author keywords

Brain tumour; Dog; Immunohistochemistry; NSAID

Indexed keywords

CYCLOOXYGENASE 2;

ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN TUMOR; DOG; DOG DISEASE; GENE EXPRESSION REGULATION; MENINGIOMA; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN NEOPLASMS; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; MENINGIOMA;

CANIS FAMILIARIS;

EID: 68549130815     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2009.00188.x     Document Type: Article

References (16)

1. Snyder JM, Shofer FS, Van Winkle TJ and Massicotte C. Canine primary intracranial neoplasia: 173 cases (1986-2003). Journal of Veterinary Internal Medicine 2006; 20: 669-675.
2. Sturges BK, Dickinson PJ, Bollen AW, Koblik PD, Kass PH, Kortz GD, Vernau KM, Knipe MF, LeCouteur RA and Higgins RJ. Magnetic resonance imaging and histological classification of intracranial meningiomas in 112 dogs. Journal of Veterinary Internal Medicine 2006; 20: 663-668.
3. Platt SR, Scase TJ, Adams V, Wieczorek L, Miller J, Adamo F and Long S. Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival. Journal of Veterinary Internal Medicine 2006; 20: 663-668.
4. Rossmeisl JH, Duncan RB, Huckle W and Troy GC. Vascular endothelial growth factor expression in tumors and plasma from dogs with primary intracranial neoplasms. American Journal of Veterinary Research 2007; 68: 1239-1245.
5. Heller DA, Fan TM, de Lorimier L-P, Charney SC, Barger AM, Tannehill-Gregg SH, Rosol TJ and Wallig MA. In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells. Journal of Veterinary Internal Medicine 2007; 21: 1048-1055.
6. Sorenmo KU, Goldshmidt MH, Shofer FS, Goldkamp C and Ferracone J. Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Veterinary and Comparative Oncology 2004; 2: 13-23.
7. Queiroga FL, Alves A, Pires I and Lopes C. Expression of COX-1 and COX-2 in canine mammary tumors. Journal of Comparative Pathology 2007; 136: 177-185.
8. Buccoliero AM, Castiglione F, Degl'Innocenti DR, Arganini L, Taddei A, Ammannati F, Mennonna P and Taddei GL. Cyclooxygenase-2 (COX-2) overexpression in meningiomas. Applied Immunohistochemistry Molecular Morphology 2007; 15: 187-192.
9. Dempke W, Rie C, Grothey A and Shmoll HJ. Cyclooxygenase-2: A novel target in cancer chemotherapy. Journal of Cancer Research and Clinical Oncology 2001; 127: 411-417.
10. Ragel BT, Jensen RL, Gillespie DL, Prescott SM and Couldwell WT. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following treatment with the inhibitor celecoxib: Potential therapeutic applications. Journal of Neurosurgery 2005; 103: 508-517.
11. Kleinheus P and Cavenee WK. WHO classification of tumors. Pathology and Genetics-Tumors of the Nervous System. Lyon, France, IARC Press, 2000; 176-184.
12. Panagopoulos AT, Lancellotti CLP, Veiga JCE, de Aguiar PHP and Colquhoun A. Expression of cell adhesion proteins and proteins related to angiogenesis in and fatty acid metabolism in benign, atypical, and anaplastic meningiomas. Journal of Neurooncology 2008; 89: 73-87.
13. Brian Jr. JE, Moore SA, Faraci Frank M. Expression and vascular effects of cyclooxygenase-2 in brain. Stroke 1998; 29: 2600-2606.
14. Maslinska D, Kaliszek A, Opertowska J, Toborowicz J, Deregowski K and Szukiewicz D. Constitutive expression of cyclooxygenase-2 (COX-2) in developing brain. A. Choroid plexus in human fetuses. Folia Neuropathologia 1999; 37: 287-291.
15. Hoffman C. COX-2 in brain and spinal cord- implications for therapeutic use. Current Medicinal Chemistry 2000; 7: 1113-1120.
16. Portnow J, Suleman S, Grossman SA, Eller S and Carson K. A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas. Neuro-oncology 2002; 4: 22-25.